We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Combination Labor Induction Method Shortens Delivery Time

By HospiMedica International staff writers
Posted on 15 Dec 2016
A combination of mechanical and pharmacologic labor induction leads to delivery several hours earlier than either method alone, claims a new study.

Researchers at the University of Pennsylvania (PA, USA) conducted a randomized trial to compare four labor induction methods: misoprostol (a prostaglandin-like drug) alone, cervical Foley catheter alone, concurrent use of misoprostol and a cervical Foley catheter, and concurrent use of a Foley catheter and the contraction-inducing hormone oxytocin. More...
In all, from May 2013 to June 2015, 491 women undergoing labor induction with full-term singleton, vertex-presenting gestations, and no contraindication to vaginal delivery participated, with the primary outcome being time to delivery.

The results showed the average time between treatment and delivery was lowest for the misoprostol-Foley combination at 13.1 hours, compared to 14.5 hours for Foley-oxytocin, 17.6 hours for misoprostol alone, and 17.7 hours for the Foley method alone. According to the researchers, the more than four-hour gap between misoprostol-Foley and either method alone is clinically meaningful, particularly considering that the various methods did not produce significant differences in the rates of cesarean deliveries or of serious medical complications for the mother or child. The study was published in the December 2016 issue of Obstetrics & Gynecology.

"Using combination methods in every case of labor induction in America would spare pregnant women more than 100,000 days of labor annually,” said lead author Lisa Levine, MD. “That in turn would reduce hospital costs, reduce the health risks to mother and child that come with prolonged labor, and reduce the stress that mothers experience while awaiting delivery.”

Labor induction is one of the most common medical procedures in the world, with nearly one million women who deliver in the United States alone undergoing the procedure annually. But despite its widespread use, including for medical conditions such as preeclampsia, gestational diabetes, or other health risks to the mother or baby, labor induction is still costly and has no widely accepted best practice guideline.

Related Links:
University of Pennsylvania


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.